EUVIMEDEUVIMED entdecken
Crossref

Beta blockers are associated with lower all-cause mortality among HFpEF patients

Joseph Ibrahim, Carly Fabrizio, Ahmet Sezer, Floyd Thoma, Brenden Boyle, Suresh R Mulukutla, Jessica H Huston, Marc A Simon, Gavin W Hickey

Clinical Research in Cardiology · 2024-06 · 113 (6) · 951-958

DOI: 10.1007/s00392-024-02451-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 02.05.2024. Verfasst von Joseph Ibrahim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Heart Failure, Stroke Volume, Cause of Death. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsHeart FailureStroke VolumeCause of DeathHumansRetrospective StudiesMaleFemaleAgedVentricular Function, LeftMiddle AgedSurvival RateAged, 80 and overAngiotensin-Converting Enzyme InhibitorsFollow-Up StudiesSpironolactone

Stichwörter der Autor:innen

Beta blockersHeart failure with preserved ejection fractionOutcomesSurvival

Substanzen

Adrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsSpironolactone

Autor:innen und Institutionen

  • Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Division of Cardiovascular Disease, Lewis Katz Temple School of Medicine, Philadelphia, PA, USA.
  • Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Ascension Saint Thomas Heart, Nashville, TN, USA.
  • Division of Cardiology, University of California San Francisco Medical Center, San Francisco, CA, USA.
  • Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. hickeygw@upmc.edu.

Zitieren

APA

Ibrahim, J., Fabrizio, C., Sezer, A., Thoma, F., Boyle, B., Mulukutla, S. R., Huston, J. H., Simon, M. A., & Hickey, G. W. (2024). Beta blockers are associated with lower all-cause mortality among HFpEF patients. Clinical Research in Cardiology, 113(6), 951-958. https://doi.org/10.1007/s00392-024-02451-0

Vancouver

Ibrahim J, Fabrizio C, Sezer A, Thoma F, Boyle B, Mulukutla SR, et al. Beta blockers are associated with lower all-cause mortality among HFpEF patients. Clinical Research in Cardiology. 2024;113(6):951-958. doi:10.1007/s00392-024-02451-0

BibTeX
@article{Ibrahim2024,
  author = {Ibrahim, Joseph and Fabrizio, Carly and Sezer, Ahmet and Thoma, Floyd and Boyle, Brenden and Mulukutla, Suresh R and Huston, Jessica H and Simon, Marc A and Hickey, Gavin W},
  title = {Beta blockers are associated with lower all-cause mortality among HFpEF patients},
  journal = {Clinical Research in Cardiology},
  year = {2024},
  volume = {113},
  number = {6},
  pages = {951--958},
  doi = {10.1007/s00392-024-02451-0}
}
Kostenlos starten →